Fig. 3
From: Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma
Kaplan–Meier curves for overall survival, progression-free survival and clinical benefit histogram of three classifications stratified according to MSI-H combined with PD-L1 CPS ≥ 5 (A–C). MSI-H, microsatellite instability-high; MSS, microsatellite stability; Mut, mutation; NDB, no durable benefit; OS, overall survival; PFS, progression-free survival; PD-L1, programmed death ligand 1; TMB, tumor mutation burden; WT, wild type